1. Home
  2. CING vs SISI Comparison

CING vs SISI Comparison

Compare CING & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • SISI
  • Stock Information
  • Founded
  • CING 2012
  • SISI 1997
  • Country
  • CING United States
  • SISI China
  • Employees
  • CING N/A
  • SISI N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • SISI Medicinal Chemicals and Botanical Products
  • Sector
  • CING Health Care
  • SISI Health Care
  • Exchange
  • CING Nasdaq
  • SISI Nasdaq
  • Market Cap
  • CING 16.2M
  • SISI 14.9M
  • IPO Year
  • CING 2021
  • SISI 2016
  • Fundamental
  • Price
  • CING $4.25
  • SISI $0.20
  • Analyst Decision
  • CING Strong Buy
  • SISI
  • Analyst Count
  • CING 4
  • SISI 0
  • Target Price
  • CING $30.67
  • SISI N/A
  • AVG Volume (30 Days)
  • CING 104.9K
  • SISI 3.4M
  • Earning Date
  • CING 08-12-2025
  • SISI 05-15-2025
  • Dividend Yield
  • CING N/A
  • SISI N/A
  • EPS Growth
  • CING N/A
  • SISI N/A
  • EPS
  • CING N/A
  • SISI N/A
  • Revenue
  • CING N/A
  • SISI $9,601,324.00
  • Revenue This Year
  • CING N/A
  • SISI N/A
  • Revenue Next Year
  • CING N/A
  • SISI N/A
  • P/E Ratio
  • CING N/A
  • SISI N/A
  • Revenue Growth
  • CING N/A
  • SISI 1133.26
  • 52 Week Low
  • CING $1.80
  • SISI $0.18
  • 52 Week High
  • CING $20.83
  • SISI $117.65
  • Technical
  • Relative Strength Index (RSI)
  • CING 59.00
  • SISI 28.38
  • Support Level
  • CING $3.97
  • SISI $0.18
  • Resistance Level
  • CING $4.26
  • SISI $0.23
  • Average True Range (ATR)
  • CING 0.27
  • SISI 0.03
  • MACD
  • CING 0.00
  • SISI 0.00
  • Stochastic Oscillator
  • CING 74.56
  • SISI 7.94

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About SISI Shineco Inc.

Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.

Share on Social Networks: